Abstract
Certain epigenetic modifications, such as the methylation of CpG sites, can serve as biomarkers for chronological age. Previously, we introduced the BayesAge frameworks for accurate age prediction through the use of locally weighted scatterplot smoothing (LOWESS) to capture the nonlinear relationship between methylation or gene expression and age, and maximum likelihood estimation (MLE) for bulk bisulfite and RNA sequencing data. Here, we introduce MicroBayesAge, a maximum likelihood framework for age prediction using DNA microarray data that provides less biased age predictions compared to commonly used linear methods. Furthermore, MicroBayesAge enhances prediction accuracy relative to previous versions of BayesAge by subdividing input data into age-specific cohorts and employing a new two-stage process for training and testing. Additionally, we explored the performance of our model for sex-specific age prediction which revealed slight improvements in accuracy for male patients, while no changes were observed for female patients.